Recent studies have shown that Ven directly increases T-cell function, while azacitidine induces a viral infection-like response in leukemic cells by activating the STING-cGAS pathway to induce a type I interferon response, thus increasing the sensitivity of AML cells to T- cell-mediated killing [56]. The gene discussed is STING1; the disease is acute myeloid leukemia.